ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Artificial Intelligence-Based Body Composition Analysis Reveals Sex-Specific Prognostic Markers and Their Clinical Value in Gastric Cancer: A Multicenter Study.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
BACKGROUND AND
aimsConventional body composition assessment fails to capture its multidimensional complexity in gastric cancer (GC). This study aimed to systematically evaluate multidimensional body composition and its clinical relevance in GC.
methods1196 GC patients and 983 healthy controls were retrospectively enrolled. Body composition was segmented using nnU-Net. Propensity score matching was used to compare body composition differences between patients and healthy controls. Prognostic value was assessed across treatment cohorts. TCGA pathological and transcriptomic data were integrated for exploratory analyses. Sex-specific prognostic models were developed and externally validated.
resultsAI-drived body compositions parameters showed sex-specific associations with survival. Higher muscle/fat area/index and lower fat density correlated with longer survival in surgical patients (L1 muscle area: HR = 0.438, ad p = 0.001). In ICI-treated females, higher subcutaneous fat area (SFA) improved survival (L2SFA: HR = 0.972, ad p = 0.045). Potential associations were observed between body composition and tumor microenvironmental features, including stromal composition, EMT-related pathways, and immune infiltration. Sex-specific prognostic models achieved C-indices of 0.723 (males) and 0.705 (females) in test cohorts, outperforming conventional predictors.
conclusionMultidimensional body composition is associated with prognosis in GC and may serve as a complementary biomarker for risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.